Patent Issued for Fluoro beta-carboline compounds (USPTO 11903949).

A patent has been issued for fluoro beta-carboline compounds by Ossifi Therapeutics LLC. The compounds and compositions described in the patent can be used to treat various bone disorders, fractures, and related issues. The invention aims to stimulate osteoblast cells to increase bone mineral deposition, which can improve bone density and promote healing. The patent provides specific formulas for the compounds and includes claims for different forms and compositions. This information may be useful for researchers and individuals interested in bone health and stem cell research. [Extracted from the article]